3M CO Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures
3M CO (MMM) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures of 723.00 thousand shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-03.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod · last filed 2026-02-03
- 3M CO share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2022-12-31 was 0.00 shares.
- 3M CO share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2022-09-30 was 0.00 shares.
- 3M CO share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2022-06-30 was 0.00 shares.
- 3M CO share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2022-03-31 was 3.78M shares.
- 3M CO share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2025 was 723.00K shares, a 36.93% increase from fiscal 2024.
- 3M CO share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2024 was 528.00K shares, a 68.33% decline from fiscal 2023.
- 3M CO share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2023 was 1.67M shares, a 55.85% decline from fiscal 2022.
- 3M CO share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2022 was 3.78M shares, a 4.54% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 12 month |
|---|---|---|---|---|
| 2025-12-31 | 723.00K shares 10-K · filed 2026-02-03 | |||
| 2024-12-31 | 528.00K shares 10-K · filed 2025-02-05 | |||
| 2023-12-31 | 1.67M shares 10-K · filed 2024-02-07 | |||
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-08 | 0.00 shares derived: sum of 2 quarters · filed 2023-02-08 | 0.00 shares derived: sum of 3 quarters · filed 2023-02-08 | 3.78M shares 10-K · filed 2023-02-08 |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-25 | 0.00 shares derived: sum of 2 quarters · filed 2022-10-25 | 3.78M shares 10-Q · filed 2022-10-25 | 3.78M shares derived: sum of 4 quarters · filed 2023-02-08 |
| 2022-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-27 | 3.78M shares 10-Q · filed 2022-07-27 | 3.78M shares derived: sum of 3 quarters · filed 2023-02-08 | |
| 2022-03-31 | 3.78M shares 10-Q · filed 2022-04-26 | 3.78M shares derived: sum of 2 quarters · filed 2023-02-08 | ||
| 2021-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-08 | 3.61M shares 10-K · filed 2023-02-08 | ||
| 2021-09-30 | 3.61M shares 10-Q · filed 2021-10-26 | |||
| 2020-12-31 | 4.78M shares 10-K · filed 2023-02-08 | |||
| 2019-12-31 | 3.43M shares 8-K · filed 2022-04-26 | |||
| 2010-09-30 | -195.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-05 | 5.79M shares 10-Q · filed 2010-11-05 | ||
| 2010-06-30 | 5.79M shares 10-Q · filed 2010-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |